Supraglottic Airway for Resuscitation in Preemies

Trial statusRecruiting
Trial phaseNot applicable
Trial typeInterventional
Biological sexAll
Age0-1
SponsorUniversity of Pennsylvania

About this trial

The goal of this single-arm intervention trial is to learn whether using a supraglottic airway (SA) as the primary interface for positive pressure ventilation (PPV) is feasible during delivery room resuscitation of premature infants. This study will be conducted in premature infants born between 29 0/7 and 33 6/7 weeks' gestation who require PPV at birth.

The main question it aims to answer is: Is it feasible to use a supraglottic airway as the primary interface to provide effective PPV during delivery room resuscitation in 29 0/7 to 33 6/7 weeks' gestation premature infants?

Participants will (1)Be screened prenatally and have informed consent obtained from the birth parent prior to delivery; (2)Be rescreened for eligibility on the day of delivery before receiving the study intervention; (3)Receive PPV using a supraglottic airway as the primary ventilation interface if resuscitation is required at birth; and (4)Have clinical and procedural data collected during delivery room resuscitation and for up to 24 hours after birth.

Eligibility criteria

This trial does not accept healthy volunteers

Qualifiers

Gestational age 29 0/7 to 33 6/7 weeks at birth

Estimated fetal weight >/= 1000 grams at birth

Clinical decision to initiate PPV

Parental informed consent

Disqualifiers

Major anomalies or aneuploidy

Palliative care planned or considered

Not resuscitated in the infant resuscitation room

Trial design

Design model

Single group

Treatments tested in this trial

  • Supraglottic Airway

    Other intervention

    Use of a supraglottic airway as the primary interface for delivery of positive pressure ventilation during neonatal resuscitation.

Treatment groups

20 Participants
are divided into 1 treatment group
Group A: Supraglottic AirwayExperimental treatment 1 intervention

Trial outcomes

Primary outcomes

1

Feasibility of Supraglottic Airway as Primary Ventilation Interface

Feasibility defined as successful use of a supraglottic airway as the primary interface to deliver positive pressure ventilation for up to 10 minutes of life or until discontinuation of positive pressure ventilation, without need for immediate escalation to an alternative airway interface.

Time frame
Immediately after birth (up to 10 minutes of life)

Secondary outcomes

1

Time to Supraglottic Airway Placement During Resuscitation

Time in minutes from birth to placement of the supraglottic airway as the primary interface for delivery of positive pressure ventilation during delivery room resuscitation.

Time frame
Immediately after birth
2

Duration of Supraglottic Airway Use During Resuscitation

Total duration in minutes that the supraglottic airway is used as the primary interface to deliver positive pressure ventilation during delivery room resuscitation.

Time frame
Immediately after birth

Other outcomes

1

Heart Rate During Resuscitation and First 24 Hours of Life

Heart rate measured in beats per minute (bpm) using continuous cardiorespiratory monitoring during neonatal resuscitation and within the first 24 hours after birth.

Time frame
Birth to 24 hours of life
2

Oxygen Saturation During Resuscitation and First 24 Hours of Life

Peripheral oxygen saturation (SpO₂), measured as a percentage using pulse oximetry during neonatal resuscitation and within the first 24 hours after birth.

Time frame
Birth to 24 hours of life
3

Need for Advanced Cardiorespiratory Interventions Within 24 Hours of Birth

Occurrence of cardiorespiratory interventions including endotracheal intubation, chest compressions, administration of epinephrine, or initiation of mechanical ventilation during resuscitation or within the first 24 hours after birth, recorded as yes/no.

Time frame
Birth to 24 hours of life

Sponsors and contacts

Click on the lead sponsor to view all of their trials.